Insider Trading: Antares Pharma Inc (ATRS.O)
ATRS.O on Consolidated Issue listed on NASDAQ Capital Market
4.06USD
17 May 2013
4.06USD
17 May 2013
Price Change (% chg)
$0.08 (+2.01%)
$0.08 (+2.01%)
Prev Close
$3.98
$3.98
Open
$4.00
$4.00
Day's High
$4.07
$4.07
Day's Low
$3.99
$3.99
Volume
1,304,583
1,304,583
Avg. Vol
944,694
944,694
52-wk High
$5.58
$5.58
52-wk Low
$2.60
$2.60
| GARRITY THOMAS JOHN | Options Exercised: 9,423 | ||
| Trade Date: | Sunday, 19 Aug 2012 | Price: | 3.97 |
| Title: | Director | Shares Held: | 103,741 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 22,827 |
Institutional Holders
| % Shares Owned: | 36.89% |
| # of Holders: | 103 |
| Total Shares Held: | 46,546,103 |
| 3 Mo. Net Change: | 1,292,335 |
| # New Positions: | 14 |
| # Closed Positions: | 12 |
| # Increased Positions: | 55 |
| # Reduced Positions: | 33 |
| # Net Buyers: | 22 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Leonard Jacob |
63 | 2008 | Independent Chairman of the Board |
Paul Wotton |
51 | 2008 | President, Chief Executive Officer, Director |
Robert Apple |
45 | 2009 | Chief Financial Officer, Executive Vice President, President - Parenteral Products Division |
Kaushik Dave |
50 | 2011 | Executive Vice President - Product Development |
Peter Sadowski |
64 | 2009 | Senior Vice President, Chief Technology Officer |
Thomas Garrity |
63 | 2003 | Independent Director |
Jacques Gonella |
70 | 2008 | Independent Director |
Anton Gueth |
55 | 2003 | Independent Director |
Eamonn Hobbs |
53 | 2009 | Independent Director |
Rajesh Shrotriya |
68 | 2004 | Independent Director |

